Work

Cost-effectiveness of Empagliflozin in Chronic Heart Failure: A Markov Model-based Analysis in Uzbekistan

Year: 2026

Type: article

Source: Cardiovascular & Haematological Disorders - Drug Targets

DOI: 10.2174/011871529x495679261009064725

Authors: Nargiza Sultanbayeva, Shakhnoz Umarova, Shokhista Iskandarova, Guzal Mullabaeva, Shohista Mukhamedova

Institution: Institute of Pharmaceutical Education and Research

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7222968024

FWCI:

Cites:

Cited by:

Related to: 10